alpha- and beta-substituted phosphonate analogs of LPA as autotaxin inhibitors.

No abstract is available for this paper.

• Publication year

  2008

• Venue

  Bioorganic & Medicinal Chemistry

• Publication date

  Unknown publication date

• Fields of study

  Medicine, Chemistry

• Identifiers
  PMID 18082408PMCID PMC2907913
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Synthesis and biological evaluation of phosphonate derivatives as autotaxin (ATX) inhibitors.

  2007cited by this paper
• LPA4/GPR23 Is a Lysophosphatidic Acid (LPA) Receptor Utilizing Gs-, Gq/Gi-mediated Calcium Signaling and G12/13-mediated Rho Activation*

  2007cited by this paper
• Inhibition of transcellular tumor cell migration and metastasis by novel carba-derivatives of cyclic phosphatidic acid.

  2007cited by this paper
• Identification of Darmstoff analogs as selective agonists and antagonists of lysophosphatidic acid receptors.

  2006cited by this paper
• GPR92 as a New G12/13- and Gq-coupled Lysophosphatidic Acid Receptor That Increases cAMP, LPA5*

  2006cited by this paper
• Carba Analogs of Cyclic Phosphatidic Acid Are Selective Inhibitors of Autotaxin and Cancer Cell Invasion and Metastasis*

  2006cited by this paper
• Synthesis and pharmacological evaluation of second-generation phosphatidic acid derivatives as lysophosphatidic acid receptor ligands.

  2006cited by this paper
• Autotaxin Is Overexpressed in Glioblastoma Multiforme and Contributes to Cell Motility of Glioblastoma by Converting Lysophosphatidylcholine TO Lysophosphatidic Acid*

  2006cited by this paper
• Synthesis, structure-activity relationships, and biological evaluation of fatty alcohol phosphates as lysophosphatidic acid receptor ligands, activators of PPARgamma, and inhibitors of autotaxin.

  2005cited by this paper
• Autotaxin (lysoPLD/NPP2) protects fibroblasts from apoptosis through its enzymatic product, lysophosphatidic acid, utilizing albumin-bound substrate.

  2005cited by this paper
• Lysophosphatidic Acid Induces Neointima Formation Through PPARγ Activation

  2004cited by this paper
• Expression, regulation and function of autotaxin in thyroid carcinomas

  2004cited by this paper
• Identification of p2y9/GPR23 as a Novel G Protein-coupled Receptor for Lysophosphatidic Acid, Structurally Distant from the Edg Family*

  2003cited by this paper
• Synthesis of alpha-fluorinated phosphonates from alpha-fluorovinylphosphonates: a new route to analogues of lysophosphatidic acid.

  2003cited by this paper
• Autotaxin Is Released from Adipocytes, Catalyzes Lysophosphatidic Acid Synthesis, and Activates Preadipocyte Proliferation

  2003cited by this paper
• Modulation of gastrointestinal wound repair and inflammation by phospholipids.

  2002cited by this paper
• Identification of Human Plasma Lysophospholipase D, a Lysophosphatidic Acid-producing Enzyme, as Autotaxin, a Multifunctional Phosphodiesterase*

  2002cited by this paper
• Autotaxin has lysophospholipase D activity leading to tumor cell growth and motility by lysophosphatidic acid production

  2002cited by this paper
• Expression of autotaxin (NPP-2) is closely linked to invasiveness of breast cancer cells

  2002cited by this paper
• Lysophosphatidic acid protects and rescues intestinal epithelial cells from radiation- and chemotherapy-induced apoptosis.

  2002cited by this paper
• Lysophosphatidic acid, a growth factor-like lipid, in the saliva Published, JLR Papers in Press,September 1, 2002. DOI 10.1194/jlr.M200242-JLR200

  2002cited by this paper
• Identification of an intracellular receptor for lysophosphatidic acid (LPA): LPA is a transcellular PPARγ agonist

  2002cited by this paper
• Autotaxin (NPP-2), a metastasis-enhancing motogen, is an angiogenic factor.

  2001cited by this paper
• Lysophosphatidic acid receptors.

  2000cited by this paper
• Ecto‐enzymes: physiology meets pathology

  2000cited by this paper
• Nucleotide Pyrophosphatases/Phosphodiesterases on the Move

  2000cited by this paper
• Lysophosphatidic acid mediates the rapid activation of platelets and endothelial cells by mildly oxidized low density lipoprotein and accumulates in human atherosclerotic lesions.

  1999cited by this paper
• Modulation of intestinal epithelial wound healing in vitro and in vivo by lysophosphatidic acid.

  1999cited by this paper
• Differential regulation of the expression of nucleotide pyrophosphatases/phosphodiesterases in rat liver.

  1999cited by this paper
• Phosphodiesterase I, A Novel Adhesion Molecule and/or Cytokine Involved in Oligodendrocyte Function

  1997cited by this paper
• Cloning, chromosomal localization, and tissue expression of autotaxin from human teratocarcinoma cells.

  1996cited by this paper
• Molecular cloning and chromosomal assignment of the human brain-type phosphodiesterase I/nucleotide pyrophosphatase gene (PDNP2).

  1995cited by this paper
• Molecular cloning, expression, and localization of a brain-specific phosphodiesterase I/nucleotide pyrophosphatase (PD-I alpha) from rat brain.

  1994cited by this paper
• Identification, purification, and partial sequence analysis of autotaxin, a novel motility-stimulating protein.

  1992cited by this paper
• Dehydration of a phosphonate substrate analogue by glycerol 3-phosphate dehydrogenase.

  1974cited by this paper

• Design and Synthesis of New α-hydroxy β-fluoro/β-trifluoromethyl and Unsaturated Phosphonates from Carbohydrate-Derived Building Blocks via Pudovik and Horner–Wadsworth–Emmons Reactions

  2022cites this paper
• Synthesis of Aminomethylene-gem-bisphosphonates Containing an Aziridine Motif: Studies of the Reaction Scope and Insight into the Mechanism.

  2021cites this paper
• Structure-Based Discovery of Novel Chemical Classes of Autotaxin Inhibitors

  2020cites this paper
• Resolution of Racemic α-Hydroxyphosphonates: Bi(OTf)3-Catalyzed Stereoselective Esterification of α-Hydroxyphosphonates with (+)-Dibenzoyl-l-tartaric Anhydride

  2019cites this paper
• New Zealand glowworm (Arachnocampa luminosa) bioluminescence is produced by a firefly-like luciferase but an entirely new luciferin

  2018cites this paper
• Development and therapeutic potential of autotaxin small molecule inhibitors: From bench to advanced clinical trials

  2018cites this paper
• Pyrrolidine and oxazolidine ring transformations in proline and serine derivatives of α-hydroxyphosphonates induced by deoxyfluorinating reagents

  2018cites this paper
• Autotaxin, a secreted lysophospholipase D, as a promising therapeutic target in chronic inflammation and cancer.

  2015cites this paper
• Considering autotaxin inhibitors in terms of 2D-QSAR and 3D-mapping- review and evaluation.

  2015cites this paper
• Catalytic Reactions in Fluorinated Phosphonates Synthesis

  2015cites this paper
• Synthesis of dialkylaminoaryl phosphonate bioisosteres of tyrosine and tyramine: a novel application of allene phosphonate chemistry for the synthesis of false substrates of tyrosinase -

  2015cites this paper
• Therapeutic Potentials of Ecto‐Nucleoside Triphosphate Diphosphohydrolase, Ecto‐Nucleotide Pyrophosphatase/Phosphodiesterase, Ecto‐5′‐Nucleotidase, and Alkaline Phosphatase Inhibitors

  2014cites this paper
• Development of lysophosphatidic acid pathway modulators as therapies for fibrosis.

  2013cites this paper
• Silver-catalyzed radical phosphonofluorination of unactivated alkenes.

  2013cites this paper
• The chemical synthesis of metabolically stabilized 2-OMe-LPA analogues and preliminary studies of their inhibitory activity toward autotaxin.

  2012cites this paper
• Chemical Evolution of Autotaxin Inhibitors

  2012cites this paper
• Developing novel organocatalyzed aldol reactions for the enantioselective synthesis of biologically active molecules.

  2011cites this paper
• Synthesis and structure-activity relationships of tyrosine-based inhibitors of autotaxin (ATX).

  2010cites this paper
• Crystallization and preliminary X-ray diffraction analysis of rat autotaxin.

  2010cites this paper
• Autotaxin and lipid signaling pathways as anticancer targets.

  2010cites this paper
• Autotaxin and lysophospholipids in rheumatoid arthritis.

  2010cites this paper
• Pharmacophore development and application toward the identification of novel, small-molecule autotaxin inhibitors.

  2010cites this paper
• Characterization of non-lipid autotaxin inhibitors.

  2010cites this paper
• Synthesis of syn-γ-Amino-β-hydroxyphosphonates by Reduction of β-Ketophosphonates Derived from L-Proline and L-Serine

  2010cites this paper
• Optimization of a pipemidic acid autotaxin inhibitor.

  2010cites this paper
• Boronic acid-based inhibitor of autotaxin reveals rapid turnover of LPA in the circulation

  2010cites this paper
• Autotaxin: a protein with two faces.

  2010cites this paper
• ATX-LPA receptor axis in inflammation and cancer

  2009cites this paper
• Novel implications for lysophospholipids, lysophosphatidic acid and sphingosine 1-phosphate, as drug targets in cancer.

  2009cites this paper
• Therapeutic potential of autotaxin/lysophospholipase d inhibitors.

  2008cites this paper
• Autotaxin inhibition: challenges and progress toward novel anti-cancer agents.

  2008cites this paper